Core Insights - The core message of the news is the official launch of Sunmax Biotech's flagship product, Deusaderm LIDO, in the Malaysian market, marking a significant step in the company's Southeast Asian strategic expansion [3][6]. Group 1: Market Expansion - The launch event in Malaysia attracted over 200 participants, including physicians, media, and industry experts from Malaysia, Singapore, the Philippines, Taiwan, and mainland China, highlighting the brand's commitment to scientific exchange and clinical practice in the aesthetic medicine sector [1][3]. - Malaysia is identified as a key market for Sunmax Biotech's regional influence, following successful entries into Singapore and the Philippines, demonstrating the company's determination to expand its global presence in the collagen aesthetic market [3][6]. Group 2: Leadership Statements - Sunmax Biotech's Chairman, Lin Qiguo, emphasized that the launch of Deusaderm LIDO in Malaysia is a milestone for expanding into the Southeast Asian market and expressed gratitude to partners and collaborators [3]. - The General Manager, Lin Mingyi, stated that after 24 years of growth and innovation, the company is dedicated to providing high-quality, pure medical-grade collagen to the global aesthetic market, and the Malaysian launch is a significant step in deepening its development in Asia [6]. Group 3: Educational Initiatives - The company plans to establish an authorized training center in Malaysia, similar to its successful model in the Philippines, to provide ongoing education and technical support to local physicians, ensuring consistency in treatment quality and brand service standards [8]. - The event featured presentations from international experts discussing various aspects of collagen therapy, including clinical applications and treatment techniques, further solidifying the company's commitment to knowledge sharing and professional development in the field [8][10]. Group 4: Recognition and Collaboration - During the event, Sunmax Biotech awarded certificates of appreciation to several top aesthetic medicine experts from different countries for their support in promoting clinical education in collagen therapy [10]. - The company also officially certified several Malaysian physicians as instructors, marking the initiation of its local collagen injection education program [10]. Group 5: Future Commitments - Sunmax Biotech aims to continue driving regional market development through innovative products and professional support, using Deusaderm LIDO as a new starting point to inject stable and profound collagen energy into the global aesthetic medicine field [13].
双美深化东南亚布局,新品于马来西亚盛大上市
Sou Hu Wang·2025-08-06 06:52